You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JNJ-42847922

Showing 1 - 25 of 430
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Impairment Trial in Orlando, Knoxville (JNJ-42847922)

Completed
  • Renal Impairment
  • JNJ-42847922
  • Orlando, Florida
  • +1 more
Jan 31, 2023

Healthy, Hepatic Impairment Trial in Kiel, Munchen (JNJ-42847922)

Completed
  • Healthy
  • Hepatic Impairment
  • JNJ-42847922
  • Kiel, Germany
  • +1 more
Mar 30, 2022

Healthy Trial in Groningen (Seltorexant)

Completed
  • Healthy
  • Groningen, Netherlands
    PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Mar 30, 2022

MDD Trial in Belgium, Germany, Netherlands (JNJ-42847922, Diphenhydramine, Placebo)

Completed
  • Major Depressive Disorder
  • JNJ-42847922
  • +2 more
  • Aalst, Belgium
  • +6 more
Feb 2, 2022

Insomnia Trial in Germany, Netherlands, United States (JNJ-42847922, Placebo)

Completed
  • Insomnia
  • JNJ-42847922
  • Placebo
  • Hollywood, Florida
  • +4 more
Jan 4, 2022

Depressive Disorder, Major Trial in Alken, Aachen (Seltorexant Dose 1, Seltorexant Dose 2, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Seltorexant Dose 1
  • +3 more
  • Alken, Belgium
  • +1 more
Aug 17, 2022

Insomnia Disorders Trial in Worldwide (Placebo, JNJ-42847922, 5 mg, JNJ-42847922, 10 mg)

Completed
Has Results
  • Insomnia Disorders
  • Placebo
  • +4 more
  • Little Rock, Arkansas
  • +55 more
May 20, 2022

Healthy Non-dependent, Recreational Sedative Users, Abuse Potential Trial in Overland Park, Montreal (Suvorexant, Zolpidem,

Recruiting
  • Healthy Non-dependent, Recreational Sedative Users
  • Abuse Potential
  • Overland Park, Kansas
  • +1 more
Jan 31, 2023

Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)

Completed
Has Results
  • Depressive Disorder, Major
  • JNJ-42847922
  • +5 more
  • Phoenix, Arizona
  • +49 more
Jul 20, 2022

Sleep Apnea, Obstructive Trial in United States (Seltorexant 40 mg, Placebo)

Completed
  • Sleep Apnea, Obstructive
  • Seltorexant 40 mg
  • Placebo
  • Atlanta, Georgia
  • +3 more
Jun 9, 2022

Alzheimer Trial in Ukraine, United States (Seltorexant, Placebo)

Recruiting
  • Alzheimer Disease
  • Peoria, Arizona
  • +32 more
Aug 17, 2022

Healthy Trial in Salt Lake City (Seltorexant)

Completed
  • Healthy
  • Salt Lake City, Utah
    PRA Health Sciences
Apr 22, 2021

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +145 more
Jan 31, 2023

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • San Diego, California
  • +26 more
Aug 17, 2022

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Terminated
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +79 more
Oct 3, 2022

Healthy Trial in Salt Lake City (Seltorexant 40 mg, Seltorexant 20 mg)

Completed
  • Healthy
  • Seltorexant 40 mg
  • Seltorexant 20 mg
  • Salt Lake City, Utah
    PRAHS
Oct 19, 2018

Healthy Trial in Merksem (Seltorexant, Placebo Matched to Seltorexant, Placebo Matched to Moxifloxacin)

Completed
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Sep 21, 2018

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Matching to Seltorexant, Quetiapine XR)

Recruiting
  • Depressive Disorder, Major
  • Birmingham, Alabama
  • +212 more
Jul 20, 2022

Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)

Not yet recruiting
  • Advanced Prostate Cancer
  • Lyon, France
  • +2 more
Oct 18, 2023

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • (no location specified)
Nov 15, 2023

Healthy Trial in Lincoln (JNJ-68179280, Placebo)

Recruiting
  • Healthy
  • Lincoln, Nebraska
    Celerion
Jan 17, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

Active, not recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Los Angeles, California
  • +6 more
Jan 18, 2023

Metastatic Castration-resistant Prostate Tumors Trial in Australia, Korea, Republic of, United States (JNJ-78278343, Cetrelimab)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Neoplasms
  • Sarasota, Florida
  • +7 more
Apr 6, 2023

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023